![](https://img.einnews.com/small/709186/shaperon.png)
Shaperon Publishes Efficacy of Next-Generation Cancer Immunotherapy in International Journal
Published in an international journal, the next-generation cancer immunotherapy shows 91.2% tumor growth inhibition and 97% metastasis prevention RESEARCH TRIANGLE PARK, NC, UNITED STATES, July 22, 2024 /EINPresswire.com/ -- Hudson Therapeutics …